<code id='D939EC2977'></code><style id='D939EC2977'></style>
    • <acronym id='D939EC2977'></acronym>
      <center id='D939EC2977'><center id='D939EC2977'><tfoot id='D939EC2977'></tfoot></center><abbr id='D939EC2977'><dir id='D939EC2977'><tfoot id='D939EC2977'></tfoot><noframes id='D939EC2977'>

    • <optgroup id='D939EC2977'><strike id='D939EC2977'><sup id='D939EC2977'></sup></strike><code id='D939EC2977'></code></optgroup>
        1. <b id='D939EC2977'><label id='D939EC2977'><select id='D939EC2977'><dt id='D939EC2977'><span id='D939EC2977'></span></dt></select></label></b><u id='D939EC2977'></u>
          <i id='D939EC2977'><strike id='D939EC2977'><tt id='D939EC2977'><pre id='D939EC2977'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:71
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          The Readout: Amylyx, Alumis, and Lundbeck drug updates
          The Readout: Amylyx, Alumis, and Lundbeck drug updates

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

          DarronCummings/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne